Table 3.

Patient profiles partitioned by the cutoff value of UAGTCR before treatments.

Group	High	Low	P value
N	20	23
Men/women	11/9	14/9	P = 0.76
Age (years)	67.0 ± 2.5	65.4 ± 2.4	P = 0.66
BMI (kg/m2)	24.1 ± 0.7	25.4 ± 0.7	P = 0.19
Treatment duration of T2D (years)	6.9 ± 1.8	7.4 ± 1.6	P = 0.82
Medications
ARB	12 (60.0%)	11 (47.8%)	P = 0.54
α-GI	4 (20.0%)	4 (17.4%)	P = 1.00
TZD	1 (5.00%)	4 (17.4%)	P = 0.35

ARB: angiotensin II receptor blockers, α-GI: α-glucosidase inhibitors, and TZD: thiazolidines.